Search
Search Results
-
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1842PDF: 491SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 5 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
714PDF: 166Supplementary: 144Appendix: 103HTML: 11 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2287PDF: 630Conflict of interest: 314SUPPLEMENTARY MATERIAL: 248HTML: 30 -
Lipoprotein(a): what clinicians need to know
177PDF: 375HTML: 18 -
-
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1031pdf: 217Supplementary Material: 35HTML: 91 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2192PDF: 372Appendix B: 425Appendix A: 313HTML: 2 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
669PDF: 1960Supplementary: 284Appendix: 230 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
710PDF: 172Supplementary: 134Appendix: 106HTML: 8 -
Evolving targets for heart failure: the journey so far
1935pdf: 281HTML: 4

